• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov13
Sellas Life Sciences released FY2025 9 Months Earnings on November 12 EST, with actual revenue of USD 0 and EPS of USD -0.1362
04:00
Sellas Life Sciences released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0626 (forecast USD -0.0766)
04:00
Aug13
Sellas Life Sciences released FY2025 Semi-Annual Earnings on August 12 (EST) with actual revenue of USD 0 and EPS of USD -0.1332
03:00
Sellas Life Sciences released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.07 (forecast USD -0.0766)
03:00
Jul15
SELLAS Life Sciences Group's SLS009 Phase 2 Trial Meets All Primary Endpoints in AML
11:46
Jul7
SELLAS Life Sciences Group Adds New Executive
13:52

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -6.791 M, EPS -0.0626

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -6.601 M, EPS -0.07

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -5.813 M, EPS -0.0662

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
EKSO
11.734
+114.91%
+6.270
PFSA
0.1335
+95.46%
+0.065
AEHL
2.050
+81.42%
+0.920
DAIC
0.6173
+56.08%
+0.220
CETX
3.145
+49.05%
+1.032
FLYE
7.750
+46.64%
+2.465
ONTF
8.030
+37.03%
+2.170
SCWO
2.338
+33.24%
+0.605
AFJK
57.710
+32.21%
+14.060
BRLS
2.100
+30.43%
+0.490
View More